Novel chitosan-magnesium aluminum silicate nanocomposite film coatings for modified-release tablets

International Journal of Pharmaceutics

Volumn 407, Issue 1-2, 2011, Pages 132-141

  Khunawattanakul, Wanwisa ^a   Puttipipatkhachorn, Satit ^b   Rades, Thomas ^c   Pongjanyakul, Thaned ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Chitosan; Drug release; Film coating; Magnesium aluminum silicate; Nanocomposite film

Indexed keywords

ATTAPULGITE; CHITOSAN; NANOCOMPOSITE; PARACETAMOL; PROPRANOLOL;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG SOLUBILITY; ENZYMATIC DEGRADATION; FILM COATING; INTESTINE FLUID; PRIORITY JOURNAL; SURFACE PROPERTY; TABLET FORMULATION; WATER TRANSPORT;

ACETAMINOPHEN; ALUMINUM SILICATES; CHITOSAN; DRUG STABILITY; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; INTESTINAL SECRETIONS; MAGNESIUM; NANOCOMPOSITES; PROPRANOLOL; SOLUBILITY; TABLETS;

EID: 79952310358     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.01.049     Document Type: Article

References (37)

1. Alexandre, M., Dubois, P., 2000. Polymer-layered silicate nanocomposites: preparation, properties and uses of a new class of materials. Mater. Sci. Eng. 28, 1-63.
2. Bauer, K.H., Lehmann, K., Osterwald, H.P., Rothgang, G., 1998. Coated Pharmaceutical Dosage Forms. Medpharm GmbH Scientific Publishers, Stuttgart.
3. Cao, Q.R., Choi, H.G., Kim, D.C., Lee, B.J., 2004. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions. Int. J. Pharm. 274, 107-117.
4. Dollery, S.C., 1991. Therapeutic Drugs. Churchill Livingstone, Edinburgh.
5. Fernández-Hervás, M.J., Fell, J.T., 1998. Pectin/chitosan mixtures as coatings for colon-specific drug delivery: an in vitro evaluation. Int. J. Pharm. 169, 115-119.
6. Günister, E., Pestreli, D., Ünlü, C.H., Atici, O., Güngör, N., 2007. Synthesis and characterization of chitosan-MMT biocomposite systems. Carbohydr. Polym. 67, 358-365.
7. Hejazi, R., Amiji, M., 2003. Chitosan-based gastrointestinal delivery systems. J. Control. Release 89, 152-165.
8. Illum, L., 1998. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15, 1326-1331.
9. Khunawattanakul, W., Puttipipatkhachorn, S., Rades, T., Pongjanyakul, T., 2008. Chitosan-magnesium aluminum silicate composite dispersions: characterization of rheology, flocculate size and zeta potential. Int. J. Pharm. 351, 227-235.
10. Khunawattanakul, W., Puttipipatkhachorn, S., Rades, T., Pongjanyakul, T., 2010. Chitosan-magnesium aluminum silicate nanocomposite films: physicochemical characterization and drug permeability. Int. J. Pharm. 393, 220-230.
11. Kibbe, H.A., 2000. Handbook of Pharmaceutical Excipients, third ed. American Pharmaceutical Association, Washington, pp. 295-298.
12. Krajewska, B., 2005. Membrane-based processes performed with use of chitin/chitosan materials. Sep. Purif. Technol. 41, 305-312.
13. Liu, K.H., Liu, T.Y., Chen, S.Y., Liu, D.M., 2007. Effect of clay content on electrostimulus deformation and volume recovery behavior of a clay-chitosan hybrid composite. Acta Biomater. 3, 919-926.
14. López-Galindo, A., Viseras, C., Cerezo, P., 2007. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Appl. Clay Sci. 36, 51-63.
15. Macleod, G.S., Collett, J.H., Fell, J.T., 1999. The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release. J. Control. Release 58, 303-310. (Pubitemid 29142454)
16. McConnell, E.L., Murdan, S., Basit, A.W., 2008. An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria. J. Pharm. Sci. 97, 3820-3829.
17. Nagai, T., Obara, S., Kokubo, H., Hoshi, N., 1997. Application of HPMC and HPMCAS to aqueous film coating of pharmaceutical dosage forms. In: McGinity, J.W. (Ed.), Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms. Marcel Dekker, Inc., New York, pp. 177-226.
18. Nakano, N.I., Shimamori, Y., Umehashi, M., Nakano, M., 1984. Preparation and drug adsorption characteristics of activated carbon beads suitable for oral administration. Chem. Pharm. Bull. 32, 699-707.
19. Nunthanid, J., Puttipipatkhachorn, S., Yamamoto, K., Peck, G.E., 2001. Physical properties and molecular behavior of chitosan films. Drug Dev. Ind. Pharm. 27, 143-157.
20. Nunthanid, J., Wanchana, S., Sriamornsak, P., Limmatavapirat, S., Luangtana-anan, M., Puttipipatkhachorn, S., 2002. Effect of heat on characteristics of chitosan film coated on theophylline tablets. Drug Dev. Ind. Pharm. 28, 919-930.
21. O'Connor, K.C., Bailey, J.E., 1988. Hydrolysis of emulsified tributyrin by porcine pancreatic lipase. Enzyme Microb. Technol. 10, 352-356.
22. Pongjanyakul, T., Priprem, A., Puttipipatkhachorn, S., 2005. Investigation of novel alginate-magnesium aluminum silicate microcomposite films for modifiedrelease tablets. J. Control. Release 107, 343-356. (Pubitemid 41316296)
23. Rojtanatanya, S., Pongjanyakul, T., 2010. Propranolol-magnesium aluminum silicate complex dispersions and particles: characterization and factors influencing drug release. Int. J. Pharm. 383, 106-115.
24. Roussy, J., Vooren, M.V., Dempsey, B.A., Guibal, E., 2005. Influence of chitosan characteristics on the coagulation and the flocculation of bentonite suspensions. Water Res. 39, 3247-3258. (Pubitemid 41138829)
25. Rowe, R.C., 1997. Defects in aqueous film-coated tablets. In: McGinity, J.W. (Ed.), Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms. Marcel Dekker, Inc., New York, pp. 419-440.
26. Sangalli, M.E., Maroni, A., Foppoli, A., Zema, L., Giordano, F., Gazzaniga, A., 2004. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances. Eur. J. Pharm. Sci. 22, 469-476.
27. Senel, S., Ikinci, G., Kaş, S., Yousefi-Rad, A., Sargon, M.F., Hincal, A.A., 2000. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int. J. Pharm. 193, 197-203.
28. Sinko, P.J., 2006. Martin's Physical Pharmacy and Pharmaceutical Sciences, fifth ed. Lippincott Williams &Wilkins, Philadelphia.
29. Sungthongjeen, S., Puttipipatkhachorn, S., Paeratakul, O., Dashevsky, A., Bodmeier, R., 2004. Development of pulsatile release tablets with swelling and rupturable layers. J. Control. Release 95, 147-159. (Pubitemid 38232672)
30. Tao, H., Wei, W., Mao, Y., Zhang, S., Xia, J., 2005. Study on degradation characteristics of chitosan by pepsin with piezoelectric quartz crystal impedance analysis technique. Anal. Sci. 21, 1057-1061.
31. Terzyk, A.P., Rychlicki, G., Biniak, S., Łukaszewicz, J.P., 2003. New correlations between the composition of the surface layer of carbon and its physicochemical properties exposed while paracetamol is adsorbed at different temperature and pH. J. Colloid Interface Sci. 257, 13-30. (Pubitemid 36074887)
32. Vishu Kumar, B.A., Tharanathan, R.N., 2004. A comparative study on depolymerization of chitosan by proteolytic enzymes. Carbohydr. Polym. 58, 275-283.
33. Vishu Kumar, B.A., Varadaraj, M.C., Tharanathan, R.N., 2007. Low molecular weight chitosan-preparation with the aid of pepsin, characterization, and its bactericidal activity. Biomacromolecules 8, 566-572. (Pubitemid 46323274)
34. Wang, X., Du, Y., Luo, J., Lin, B., Kennedy, J.F., 2007. Chitosan/organic rectorite nanocomposite films: structure, characteristic and drug delivery behaviour. Carbohydr. Polym. 69, 41-49.
35. Wu, S.H.W., Wyatt, D.M., Adams, M.W., 1997. Chemistry and applications of cellulosic polymers for enteric coatings of solid dosage forms. In: McGinity, J.W. (Ed.), Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms. Marcel Dekker, Inc., New York, pp. 385-418.
36. Yoshizawa, T., Shin-ya, Y., Hong, K.J., Kajiuchi, T., 2005. pH- and temperature-sensitive release behaviors from polyelectrolyte complex films composed of chitosan and PAOMA copolymer. Eur. J. Pharm. Biopharm. 59, 307-313.
37. Zhang, H., Alsarra, I.A., Neau, S.H., 2002. An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int. J. Pharm. 239, 197-205.